<https://www.bigmoleculewatch.com/2022/03/21/jama-oncology-publishes-results-of-phase-iii-study-for-prestige-biopharmas-herceptin-biosimilar-hd201/#primaryimage>
<http://schema.org/height>
"170"^^<http://www.w3.org/2001/XMLSchema#integer>
<https://www.bigmoleculewatch.com/2022/03/21/jama-oncology-publishes-results-of-phase-iii-study-for-prestige-biopharmas-herceptin-biosimilar-hd201/>